Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Vivo Capital
AddedFeb 13, 2024
UpdatedJul 16, 2026
Vivo Capital

Vivo Capital

Operating

Vivo Capital LLC: A healthcare-focused investment firm operating in the US and China.

Location
Palo Alto, CA, US
Founded
1996
Firm
Compare
Portfolio
Employees
Website

Vivo Capital LLC is a healthcare-focused investment firm that operates primarily in the United States and China. The firm invests across various stages, including Series A, B, C, and D rounds, with occasional involvement in seed and private equity rounds. Vivo Capital targets sectors such as therapeutics, pharmaceuticals, and other healthcare-related industries.

Notable portfolio companies include Aadi Bioscience, Aclaris Therapeutics, Aligos Therapeutics, and Harmony Biosciences. Key decision-makers at Vivo Capital include Managing Partners Gaurav Aggarwal and Michael Chang. The firm emphasizes a hands-on investment philosophy, offering strategic guidance and leveraging its extensive network to add value to its portfolio companies.

Vivo Capital - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments102
Current Portfolio Count64
Total Portfolio Exits3

Top Investment Stages

Series A25 (28.7%)
Series B24 (27.6%)
Series C18 (20.7%)
Post Ipo Equity10 (11.5%)
Series D10 (11.5%)

Stage Mix

Series A 29%Series B 28%Series C 21%Post Ipo Equity 11%Series D 11%

Concentration shown as share of disclosed investments by stage.

Recent Investments

SonoThera logo

SonoThera

Silence Therapeutics logo

Silence Therapeutics

Adarx Pharmaceuticals logo

Adarx Pharmaceuticals

Ossium Health logo

Ossium Health

EpiBiologics logo

EpiBiologics

Delcath Systems logo

Delcath Systems

Unicycive Therapeutics logo

Unicycive Therapeutics

Rgenta Therapeutics logo

Rgenta Therapeutics

Bonum Therapeutics logo

Bonum Therapeutics

Neocis logo

Neocis

Inspirna logo

Inspirna

Tebra logo

Tebra

Cerebral Therapeutics logo

Cerebral Therapeutics

Ocelot Bio logo

Ocelot Bio

HistoWiz logo

HistoWiz

Inbrace logo

Inbrace

Attralus logo

Attralus

Whitehawk Therapeutics logo

Whitehawk Therapeutics

Neurogastrx logo

Neurogastrx

Scientia Vascular logo

Scientia Vascular

Aerobiotix logo

Aerobiotix

Sera Prognostics logo

Sera Prognostics

Immune-Onc Therapeutics logo

Immune-Onc Therapeutics

Fortis Therapeutics logo

Fortis Therapeutics

BlossomHill Therapeutics logo

BlossomHill Therapeutics

Vivo Capital - Similar Investment Firms

InVivium Capital logo

InVivium Capital

invivium.com

Vida Ventures logo

Vida Ventures

vidaventures.com

Avoro Capital Advisors logo

Avoro Capital Advisors

avorocapital.com

Lyfe Capital logo

Lyfe Capital

lyfecapital.com

Endpoint Ventures logo

Endpoint Ventures

endpoint.vc

V Capital logo

V Capital

vcapital.com

Vive Collective logo

Vive Collective

vivecollective.com

venBio Partners logo

venBio Partners

venbio.com

Healthcare Ventures logo

Healthcare Ventures

hcven.com

Venture Investors logo

Venture Investors

Pivotal bioVenture Partners logo

Pivotal bioVenture Partners

Decheng Capital logo

Decheng Capital

decheng.com

Vocap Investment Partners logo

Vocap Investment Partners

vocap.vc

Bioventures Investors logo

Bioventures Investors

Aphelion Capital logo

Aphelion Capital

Vivo Capital - Classification

Also Known As
  • Vivo Capital, LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end